Ethan Chad Baker

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Novozymes A/s. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ethan Chad Baker. Retrieved from https://idiyas.com/inventor/ethan-chad-baker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 5 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.3

ph-index = 1

Company Filing History:

5 out of 1,427

Novozymes A/s

patents

Years Active: 2020-2025

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12440518 - strains for improving feed conversion rates and body weight gain in animals (2025-10-14),

2. 12171792 - Bacillus strains for improving feed conversion rates and body weight gain in animals (2024-12-24),

3. 11819525 - Management of pathogenic (2023-11-21),

4. 11478514 - Management of pathogenic (2022-10-25),

5. 10675589 - Cleaning of water filtration membranes (2020-06-09),

Title: Innovations by Ethan Chad Baker

Introduction

Ethan Chad Baker is a notable inventor based in Roanoke, VA (US). He has made significant contributions to the field of animal feed additives, focusing on improving feed conversion rates and body weight gain in animals. With a total of 5 patents, his work has the potential to enhance animal health and performance.

Latest Patents

Ethan's latest patents include innovative strains designed to improve feed conversion rates and body weight gain in animals. One of his notable inventions is strain O42AH3 (deposit accession number DSM 32559), which, along with strains O52YJ6 (DSM 32560), O52YYT (DSM 32561), and O72NR7 (DSM 32563), is useful for preventing and treating Lawsonia infections. These strains contribute to improving various performance parameters, including body weight gain and average daily gain. Additionally, his compositions comprising O72NR7 (DSM 32563) are effective in enhancing performance metrics when fed to animals.

Career Highlights

Ethan Chad Baker is currently associated with Novozymes A/S, where he continues to innovate in the field of animal nutrition. His work is pivotal in developing solutions that address the challenges faced in animal husbandry.

Collaborations

Ethan collaborates with talented individuals such as Adam Nelson and Erik Eckhardt, contributing to a dynamic team focused on advancing animal feed technology.

Conclusion

Ethan Chad Baker's contributions to animal feed innovation demonstrate his commitment to improving agricultural practices. His patents reflect a deep understanding of animal health and nutrition, positioning him as a key figure in this important field.

Profile summary based on public USPTO records.